The technology used in the portable, handheld device went through 10 years of research and development.

The Israeli pharma-tech company Syqe Medical has received approval from Canadian health officials to sell its metered-dose medical cannabis inhaler in Canada, the company announced on Wednesday.

The Syqe Inhaler—the first pharmaceutical-grade medical-cannabis delivery device—releases a controlled amount of cannabinoids through each inhalation, ensuring that medical marijuana patients receive the proper dose.

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

The technology used in the portable, handheld device went through 10 years of research and development, including testing in a number of research trials, said Michael Milloy, general manager of Syqe Medical in Canada.

The inhaler will be available to patients in Canada with medical authorization through Syqe Medical Canada, in partnership with a Canadian licensed producer. Read more at JNS